title: Vif Proteins from Diverse Human Immunodeficiency Virus/Simian Immunodeficiency Virus Lineages Have Distinct Binding Sites in A3C.
abstract: Lentiviruses have evolved the Vif protein to counteract APOBEC3 (A3) restriction factors by targeting them for proteasomal degradation. Previous studies have identified important residues in the interface of human immunodeficiency virus type 1 (HIV-1) Vif and human APOBEC3C (hA3C) or human APOBEC3F (hA3F). However, the interaction between primate A3C proteins and HIV-1 Vif or natural HIV-1 Vif variants is still poorly understood. Here, we report that HIV-1 Vif is inactive against A3Cs of rhesus macaques (rhA3C), sooty mangabey monkeys (smmA3C), and African green monkeys (agmA3C), while HIV-2, African green monkey simian immunodeficiency virus (SIVagm), and SIVmac Vif proteins efficiently mediate the depletion of all tested A3Cs. We identified that residues N/H130 and Q133 in rhA3C and smmA3C are determinants for this HIV-1 Vif-triggered counteraction. We also found that the HIV-1 Vif interaction sites in helix 4 of hA3C and hA3F differ. Vif alleles from diverse HIV-1 subtypes were tested for degradation activities related to hA3C. The subtype F-1 Vif was identified to be inactive for degradation of hA3C and hA3F. The residues that determined F-1 Vif inactivity in the degradation of A3C/A3F were located in the C-terminal region (K167 and D182). Structural analysis of F-1 Vif revealed that impairing the internal salt bridge of E171-K167 restored reduction capacities to A3C/A3F. Furthermore, we found that D101 could also form an internal interaction with K167. Replacing D101 with glycine and R167 with lysine in NL4-3 Vif impaired its counteractivity to A3F and A3C. This finding indicates that internal interactions outside the A3 binding region in HIV-1 Vif influence the capacity to induce degradation of A3C/A3F.
  
  
  OBJECTIVE
  The APOBEC3 restriction factors can serve as potential barriers to lentiviral cross-species transmissions. Vif proteins from lentiviruses counteract APOBEC3 by proteasomal degradation. In this study, we found that monkey-derived A3C, rhA3C and smmA3C, were resistant to HIV-1 Vif. This was determined by A3C residues N/H130 and Q133. However, HIV-2, SIVagm, and SIVmac Vif proteins were found to be able to mediate the depletion of all tested primate A3C proteins. In addition, we identified a natural HIV-1 Vif (F-1 Vif) that was inactive in the degradation of hA3C/hA3F. Here, we provide for the first time a model that explains how an internal salt bridge of E171-K167-D101 influences Vif-mediated degradation of hA3C/hA3F. This finding provides a novel way to develop HIV-1 inhibitors by targeting the internal interactions of the Vif protein.
authors: Clinic for Gastroenterology, Hepatology, and Infectiology, Medical Faculty, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany.
authors: Zeli
authors: Z
authors: Zhang
authors: Clinic for Gastroenterology, Hepatology, and Infectiology, Medical Faculty, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany.
authors: Qinyong
authors: Q
authors: Gu
authors: Clinic for Gastroenterology, Hepatology, and Infectiology, Medical Faculty, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany.
authors: Ananda Ayyappan
authors: AA
authors: Jaguva Vasudevan
authors: Clinic for Gastroenterology, Hepatology, and Infectiology, Medical Faculty, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany.
authors: Manimehalai
authors: M
authors: Jeyaraj
authors: Department of Medical Biotechnology, Paul-Ehrlich-Institut, Langen, Germany.
authors: Stanislaw
authors: S
authors: Schmidt
authors: Clinic for Gastroenterology, Hepatology, and Infectiology, Medical Faculty, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany.
authors: Jörg
authors: J
authors: Zielonka
authors: Clinic for Gastroenterology, Hepatology, and Infectiology, Medical Faculty, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany.|Department of Medical Biotechnology, Paul-Ehrlich-Institut, Langen, Germany.
authors: Mario
authors: M
authors: Perković
authors: Zoo Landau in der Pfalz, Landau in der Pfalz, Germany.
authors: Jens-Ove
authors: JO
authors: Heckel
authors: Department of Medical Biotechnology, Paul-Ehrlich-Institut, Langen, Germany.
authors: Klaus
authors: K
authors: Cichutek
authors: Clinic for Gastroenterology, Hepatology, and Infectiology, Medical Faculty, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany.
authors: Dieter
authors: D
authors: Häussinger
authors: Institute of Biochemistry, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany.
authors: Sander H J
authors: SHJ
authors: Smits
authors: Clinic for Gastroenterology, Hepatology, and Infectiology, Medical Faculty, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany carsten.muenk@med.uni-duesseldorf.de.
authors: Carsten
authors: C
authors: Münk
mesh_terms: D000818:Animals; D001665:Binding Sites; D002460:Cell Line; D003564:Cytidine Deaminase / Q000378:metabolism*; D016346:Gene Products, vif / Q000378:metabolism*; D057809:HEK293 Cells; D015658:HIV Infections / Q000821:virology; D015497:HIV-1 / Q000378:metabolism*; D015498:HIV-2 / Q000378:metabolism; D006801:Humans; D016086:Lentivirus / Q000378:metabolism; D008253:Macaca mulatta; D011485:Protein Binding / Q000502:physiology; D015302:Simian Immunodeficiency Virus / Q000378:metabolism*; D054320:vif Gene Products, Human Immunodeficiency Virus / Q000378:metabolism*
chemical_list: D016346:Gene Products, vif; D054320:vif Gene Products, Human Immunodeficiency Virus; D003564:Cytidine Deaminase